Core Insights - On September 11, 2025, Aojing Medical experienced a block trade at a price of 26.54 yuan, representing a discount of 1.48% compared to the closing price of the same day [1] - The total volume of the block trade was 400,000 shares, amounting to 10.616 million yuan, with the buyer being an institutional client and the seller being Huatai Securities [1] - Over the past three months, the stock has seen four block trades totaling 11,000 hands, all executed at a discount, with no new shares unlocked recently [1] Trading Performance - As of the close on September 11, 2025, Aojing Medical (688613) closed at 26.94 yuan, reflecting an increase of 5.98% with a turnover rate of 10.32% and a trading volume of 141,400 hands, resulting in a total transaction value of 374 million yuan [1] - In the last six months, there has been a net reduction of 345,100 shares held by shareholders, with specific details of the changes provided [1] Shareholder Activity - BioVeda China RMB Investment Limited reduced its holdings by 345,100 shares on May 25, 2025, which is a decrease of 0.25%, leaving them with 7,239,400 shares, representing 5.28% of the total share capital [1]

Group 1 - On September 11, Aojing Medical executed a block trade of 400,000 shares, with a transaction value of 10.616 million yuan, accounting for 2.76% of the total trading volume for that day [1] - The transaction price was 26.54 yuan, which represents a discount of 1.48% compared to the market closing price of 26.94 yuan [1] - The trade was conducted through Huatai Securities, indicating institutional interest in the stock [2]

Core Viewpoint - The stock of Aojing Medical (688613) has experienced a decline of 4.4% as of September 10, 2025, closing at 25.42 yuan, with significant net outflows from major funds and a mixed performance from retail investors [1][2]. Financial Performance - Aojing Medical reported a main revenue of 100 million yuan for the first half of 2025, a year-on-year decrease of 0.2% [5]. - The net profit attributable to shareholders was 7.9753 million yuan, down 13.52% year-on-year [5]. - The second quarter of 2025 showed a single-quarter main revenue of 57.5772 million yuan, an increase of 8.88% year-on-year, and a net profit of 6.9338 million yuan, up 203.59% year-on-year [5]. Market Activity - On September 10, 2025, the stock had a trading volume of 134,700 hands and a transaction amount of 341 million yuan [1]. - The net outflow of major funds was 45.0152 million yuan, accounting for 13.21% of the total transaction amount, while retail investors saw a net inflow of 33.3271 million yuan, representing 9.78% of the total [1][2]. Financing and Margin Trading - As of September 10, 2025, the financing balance was 178 million yuan, with a net financing purchase of 2.518 million yuan [3]. - There were no short selling activities reported on that day, indicating a stable margin trading environment [3]. Industry Comparison - Aojing Medical's total market capitalization is 3.483 billion yuan, significantly lower than the industry average of 12.107 billion yuan, ranking 97 out of 123 in the medical device sector [5]. - The company's gross margin stands at 63.12%, which is above the industry average of 51.85%, ranking 42 out of 123 [5].

奥精医疗9月10日大宗交易平台出现一笔成交，成交量20.00万股，成交金额500.80万元，大宗交易成交 价为25.04元，相对今日收盘价折价1.49%。该笔交易的买方营业部为机构专用，卖方营业部为华泰证券 股份有限公司南京中山东路华泰证券大厦证券营业部。 进一步统计，近3个月内该股累计发生3笔大宗交易，合计成交金额为1794.70万元。 证券时报•数据宝统计显示，奥精医疗今日收盘价为25.42元，下跌4.40%，日换手率为9.83%，成交额为 3.41亿元，全天主力资金净流出4041.80万元，近5日该股累计上涨28.45%，近5日资金合计净流入12.01 万元。 两融数据显示，该股最新融资余额为1.75亿元，近5日增加2110.33万元，增幅为13.69%。（数据宝） 9月10日奥精医疗大宗交易一览 | 成交量 | 成交金 | 成交价 | 相对当日 | | | | --- | --- | --- | --- | --- | --- | | | 额 | 格 | 收盘折溢 | 买方营业 | 卖方营业部 | | （万 | （万 | | 价 | 部 | | | 股） | 元） | （元） | | | | | | ...

| 交易日期 | 证券商除 | 证券代码 | 成交价(元) 成交盘额(万元) 成交量(*) 买入营业部 | | | | 奥出营业那 | 是否为专场 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-09-10 | 奥精医疗 | 688613 | 25.04 500.8 | 20 | 机构专用 | 华泰证券股份有限 公司南京中山东路 | | 15 | | | | | | | | 华泰证券大厦证券 MALL AN | | | 9月10日，奥精医疗大宗交易成交20万股，成交额500.8万元，占当日总成交额的1.45%，成交价25.04 元，较市场收盘价25.42元折价1.49%。 ...

进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为1293.90万元。 证券时报·数据宝统计显示，奥精医疗今日收盘价为26.59元，上涨3.06%，日换手率为17.00%，成交额 为6.11亿元，全天主力资金净流出218.73万元，近5日该股累计上涨32.68%，近5日资金合计净流入 3877.74万元。 奥精医疗9月9日大宗交易平台出现一笔成交，成交量30.00万股，成交金额785.70万元，大宗交易成交价 为26.19元，相对今日收盘价折价1.50%。该笔交易的买方营业部为机构专用，卖方营业部为华泰证券股 份有限公司南京中山东路华泰证券大厦证券营业部。 （文章来源：证券时报网） | 成交量 | 成交金额 | 成交价格 | 相对当日收盘折 | 买方 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | | （万股） | （万元） | （元） | 溢价（%） | 营业 | | | | | | | 部 | | | 30.00 | 785.70 | 26.19 | -1.50 | 机构 | 华泰证券股份有限公司南京中山东路华 | | | | | | 专用 | ...

进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为1293.9万元。该股近5个交易日累 计上涨32.68%，主力资金合计净流入3540.16万元。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 9月9日，奥精医疗收涨3.06%，收盘价为26.59元，发生1笔大宗交易，合计成交量30万股，成交金额 785.7万元。 第1笔成交价格为26.19元，成交30.00万股，成交金额785.70万元，溢价率为-1.50%，买方营业部为机构 专用，卖方营业部为华泰证券股份有限公司南京中山东路华泰证券大厦证券营业部。 责任编辑：小浪快报 ...

9月9日，奥精医疗大宗交易成交30万股，成交额785.7万元，占当日总成交额的1.27%，成交价26.19 元，较市场收盘价26.59元折价1.5%。 | 交易日期 | · 证券商标 | 证券代码 | 成交价(元) 成交宜额(万元) 成交量(*) 买入营业部 | | | | 奥出营业服 | 是否为变场 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-09-09 | 奥精医疗 | 688613 | 26.19 785.7 | 30 | 机构专用 | 华泰证券股份有限 公司南京中山东路 | | 15 | | | | | | | | 华泰证券大厦证券 MALL AR | | | ...

（编辑 姚尧） 证券日报网讯 9月8日晚间，奥精医疗发布公告称，公司股票交易连续3个交易日内（2025年9月4日、 2025年9月5日、2025年9月8日）收盘价格涨幅偏离值累计达到30%，属于股票交易异常波动情形。经公 司自查，并发函问询实际控制人，截至2025年9月8日，确认不存在应披露而未披露的重大事项。 ...

Group 1 - The core transaction of Aojing Medical on September 8 involved a block trade of 200,000 shares, amounting to 5.082 million yuan, with a transaction price of 25.41 yuan, reflecting a discount of 1.51% compared to the closing price of the day [2] - Aojing Medical's closing price on the same day was 25.80 yuan, showing an increase of 20.00%, with a turnover rate of 17.34% and a total trading volume of 589 million yuan, indicating a net inflow of main funds amounting to 36.2489 million yuan [2] - Over the past five days, Aojing Medical's stock has risen by 25.24%, with a total net inflow of funds reaching 36.8768 million yuan [2] Group 2 - The latest margin financing balance for Aojing Medical is 158 million yuan, which has increased by 14.0874 million yuan over the past five days, representing a growth rate of 9.79% [2]